Philadelphia, PANCT02469662Now EnrollingIRB Ready

Elbow Joint Destruction Clinical Trial in Philadelphia, PA

Access cutting-edge elbow joint destruction treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by Zimmer Biomet

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access elbow joint destruction specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related elbow joint destruction treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this elbow joint destruction clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Elbow Joint Destruction Study in Philadelphia

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.

Sponsor: Zimmer Biomet

Who Can Participate

Inclusion Criteria

Patient is 18 years of age or older.
Patient must have signed Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent.
Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the following:
Elbow joint destruction which significantly compromises daily living activities
Post-traumatic lesions or bone loss contributing to elbow instability
Ankylosed joints, especially cases of bilateral ankylosis from causes other than active sepsis
Advanced rheumatoid arthritis, post-traumatic, or degenerative arthritis with incapacitating pain
Instability or loss of motion when the degree of joint or soft tissue damage precludes reliable osteosynthesis
Acute comminuted articular fracture of elbow joint surfaces that precludes less radical procedures, including 13-C3 fractures of the distal humerus
Patient is willing and able to complete scheduled follow-up evaluations as defined by the protocol. Additional Retrospective Arm Inclusion Criteria
Patient must have undergone a total elbow replacement with the Nexel system between July 2013 and the date of the site initiation visit.
Patient information available for each retrospective patient must, at minimum, include preoperative demographic information, preoperative physical exam information, the index surgery operative report, and details of the devices implanted.

Exclusion Criteria

Patient has a currently active or history of repeated local infection at the surgical site.
Patient has a current major infection distant from the operative site.
Patient has a history of prior sepsis.
Patient suffers from paralysis or dysfunctional neuropathy at the elbow joint.
Patient has significant ipsilateral hand dysfunction.
Patient has excessive scarring near the surgical site, which could prevent adequate soft tissue coverage.
Patient participates in daily activities that may cause significant stress to an implanted device such as heavy labor, torsional stress, and/or competitive sports.
Patient is a prisoner.
Patient is mentally incompetent or unable to understand what participation in the study entails.
Patient is a known alcohol or drug abuser.
Patient is anticipated to be non-compliant.
Patient is known to be pregnant.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT02469662) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Elbow Joint Destruction Treatment Options in Philadelphia, PA

If you're searching for elbow joint destruction treatment options in Philadelphia, PA, this clinical trial (NCT02469662) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced elbow joint destruction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all elbow joint destruction clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Philadelphia, PA

See all ulcerative colitis clinical trials recruiting in Philadelphia — not just this study.

Browse Ulcerative Colitis Trials in Philadelphia →

Browse More Trials by Condition

Ulcerative Colitis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA